MIT’s Koch Institute is part of new pancreatic cancer consortium
This ambitious undertaking will be led by 11 leading cancer researchers at the following participating institutions:
- Cold Spring Harbor Laboratory
- Dana-Farber Cancer Institute in affiliation with Harvard Medical School
- The David H. Koch Institute for Integrative Cancer Research at MIT
- Johns Hopkins University School of Medicine
- Memorial Sloan-Kettering Cancer Center
- The University of Texas M. D. Anderson Cancer Center
As part of PCRC, the scientists will share knowledge, information, expertise and technologies in a coordinated effort. The consortium will make recommendations on how to allocate funds and assess the ongoing progress of the research being conducted. Additional funding decisions will be announced by the Foundation as they are determined.
“Our strategy of focused research has produced significant advances in understanding pancreatic cancer, including identifying the genes involved in this disease,” said Dr. Robert Vizza, president of The Lustgarten Foundation. “The Pancreatic Cancer Research Consortium will build on these advances by bringing together exceptional scientists and institutions who will lead the field toward a cure for the deadliest of all cancers.”
About The Lustgarten Foundation and Pancreatic Cancer
The Lustgarten Foundation, based in Bethpage, N.Y., is America’s largest private foundation dedicated solely to funding pancreatic cancer research. Founded in 1998, the Foundation provides critical support in the search for better diagnostics and treatment of pancreatic cancer, and to date has provided more than $32 million to more than 115 research projects at 41 medical and research centers worldwide.